Well one thing's for sure, ADO management scoffed at $1 per test revenue to ADO as completely unrealistic.(Per roadshow reports from Melbourne.)
So what IS a realistic cut? They gave absolutely no indication.
Unless Ellume manages to get colossal numbers of tests, it seems we aren't going to see significant revenue.
The potential rivers of gold for ADO have been batteries for a long time now. Diagnostic testing revenues might be nice.
Ellume, partner or not?, page-18
-
- There are more pages in this discussion • 202 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $46.90M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.9¢ | $23.42K | 1.233M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1142321 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 339684 | 2 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| ADO (ASX) Chart |